Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Metronidazole paten harga?Lorazepam nasal spray?Oseltamivir phosphate 75 mg price?Leading pharma lorazepam recall?Drugs like modafinil?
See the DrugPatentWatch profile for miebo
The generic name for Miebo is perfluorohexyloctane [1]. Perfluorohexyloctane is an ophthalmic solution indicated for the treatment of the signs and symptoms of dry eye disease [1].
The active ingredient in Miebo is perfluorohexyloctane [1]. It is a semi-fluorinated alkane that acts as a tear substitute [2].
Perfluorohexyloctane forms a lipid layer on the surface of the eye. This layer helps to reduce tear evaporation by creating a barrier that stabilizes the tear film [2]. By preventing rapid evaporation of tears, it can alleviate the discomfort associated with dry eye disease.
Information regarding specific patent expiry dates for Miebo can be found on DrugPatentWatch.com [3]. This resource tracks pharmaceutical patents and can provide details on when patent protection is set to end, which is relevant for potential generic entry.
Miebo is developed by Bausch + Lomb [1].
Other Questions About Miebo :